Gabriela Apiou, PhD, has been named inaugural incumbent of the recently established Endowed MGH Research Institute Chair in Translational Sciences.

This new chair was made possible through a generous and visionary gift from an anonymous donor to further the mission of translating cutting-edge research into improved clinical care for patients.

Dr. Apiou is the leader of the Longfellow Project – an initiative housed in the Office of the Scientific Director of the Mass General Research Institute, designed to accelerate the translation of research at Mass General to patients around the world through transformative models of collaboration across academia and the biopharmaceutical industry.

Dr. Apiou graduated from University of Transylvania, Romania with a bachelor’s degree in Mechanical Engineering. She received her PhD in Biomedical Engineering from Ecole Nationale Supérieure des Arts et Métiers Angers, France and her Habilitation à Diriger des Recherches in Health and Life Sciences from University of Paris Est Créteil, France.

Between 1995 and 2011, she worked for global leaders in the biomedical engineering and pharmaceutical industry, where she built and established an international research and development entity focusing on inhaled therapeutics and delivery devices. Her expertise is in applying physics and engineering principles to solve relevant clinical problems and in translational sciences.

Since 2011, she has been working at Mass General as the Director of the Translational Research Core in the Wellman Center for Photomedicine and since 2015 as the Director of Strategic Alliances in the Office of the Scientific Director of the Mass General Research Institute.

Dr. Apiou’s primary focus is on teaching and practicing unique models of innovation through collaboration across academia and industry to deliver new solutions to major health care challenges.

About the Mass General Research Institute
Research at Massachusetts General Hospital is interwoven through more than 30 different departments, centers and institutes. Our research includes fundamental, lab-based science; clinical trials to test new drugs, devices and diagnostic tools; and community and population-based research to improve health outcomes across populations and eliminate disparities in care.
Support our Research